Combining COPD with Clinical, Pathological and Demographic Information Refines Prognosis and Treatment Response Prediction of Non-Small Cell Lung Cancer
Comprehensive prognostic model for lung adenocarcinoma.
Patient survival at 60 months for the total population sample is shown for the range of Hazard Scores (left), with the risk-groups delimited by vertical bars. Model coefficients used to determine the Hazard Score for each patient are shown on the forest plot (right). A: AJCC 3rd Staging Edition; B: AJCC 6th Staging Edition; C: AJCC 7th Staging Edition.